The present invention relates to a new cyclic peptide compound or a salt thereof,which has anti-hepatitis C virus activities based on inhibitory activity againstthe RNA replication of hepatitis C virus replicon, a process for preparationthereof, a pharmaceutical composition comprising the same, and a method forprophylactic and/or therapeutic treatment of hepatitis C in a human being oran animal.